iTonic (ITOC) vs Outset Medical (OM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Outset Medical (OM) has outperformed iTonic (ITOC) over the past year, losing 34.5% versus a loss of 82.0%. Outset Medical is the larger company by market cap ($53.0 million vs $11.6 million), about 4.6 times the size, while iTonic is growing revenue faster (+16.7% vs +5.1%). Outset Medical converts more of its revenue into profit, with a net margin of -68.3% versus -974.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ITOC | OM |
|---|---|---|
| Share price | $1.59 | $2.81 |
| Market cap | $11.63M | $53.03M |
| 1-day change | +6.00% | -3.44% |
| YTD return | -76.40% | -24.26% |
| 1-year return | -81.96% | -34.50% |
| 5-year return | — | -99.61% |
| EPS (TTM) | $-4.22 | $-3.78 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $523.03K | $119.48M |
| Revenue growth (YoY) | +16.70% | +5.09% |
| Net income (latest FY) | $-5.10M | $-81.65M |
| Gross margin | 62.59% | 39.13% |
| Operating margin | -991.71% | -55.83% |
| Net margin | -974.68% | -68.34% |
| 52-week high | $18.40 | $6.49 |
| 52-week low | $1.40 | $2.77 |
| Distance from 52-week high | -91.36% | -56.70% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +172.95% |
| Average volume | 42.84K | 140.40K |
| Shares outstanding | 6.84M | 18.87M |
| Employees | 7 | 310 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Outset Medical is about 4.6 times larger than iTonic by market value ($53.03M vs $11.63M).
- OM has outperformed ITOC by 47.5 percentage points over the past year.
- Outset Medical is more profitable, keeping -68.3 cents of every revenue dollar as net income versus -974.7 cents for iTonic.
- iTonic grew revenue faster in its latest fiscal year (+16.70% vs +5.09%).
About iTonic
ITOC stock →iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 7 employees
About Outset Medical
OM stock →Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 310 employees
ITOC vs OM FAQ
Which is bigger, iTonic or Outset Medical?
Outset Medical (OM) is larger, with a market capitalization of $53.03M compared with $11.63M for iTonic (ITOC).
Which stock has performed better over the past year, ITOC or OM?
OM returned -34.50% over the past 12 months, compared with -81.96% for ITOC (price return, excluding dividends). Past performance does not predict future results.
Are iTonic and Outset Medical in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.